Middle East and Africa Menopausal Disorder Treatment Market – Industry Trends and Forecast to 2030

Middle East and Africa Menopausal Disorder Treatment Market, By Stages (Menopause, Postmenopause, Perimenopause), Type (Hormonal Therapy and Non-Hormonal Therapy), Menopause Symptoms (Vasomotor Symptoms, Atrophic Vaginitis, Osteoporosis, Joint Pain, Weight Gain, Dyspareunia, Depression, Others), Dosage Form (Tablet, Cream, Gels, Rings/Insert, Patch/Film, Injection Shot, Spray, Others), Route of Administration (Oral, Vaginal, Transdermal, Parenteral), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2030.

Middle East and Africa Menopausal Disorder Treatment Market Analysis and Size

Menopause is one of the most physically demanding times in any women’s life, boosting pharmaceutical companies globally to create effective medications to treat it and its associated problems. The incidence of menopause is expected to be around 50 million cases yearly. Menopause naturally occurs in women between the age group of 49 to 52 of age. The World Health Organization (WHO) projects an increase in the proportion of adults over age 60 years in sub-Saharan Africa from 46 million people in 2015 to 157 million by 2050.

Data Bridge Market Research analyses a growth rate in the menopausal disorder treatment market in the forecast period 2023-2030. The expected CAGR of menopausal disorder treatment market is tend to be around 5.8% in the mentioned forecast period. The market value is USD 402.3 million in 2022, and it would grow upto USD 631.5 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Middle East and Africa Menopausal Disorder Treatment Market Scope and Segmentation

Market Definition

Menopause is a natural biological process that occurs because of the reduction of reproductive hormones. This marks the end of the menstrual cycle. It generally occurs in the age of late 40s or 50s. The menopause symptoms are different for every women. Every woman experiences these menopause symptoms in a different way. Estrogen levels decline throughout menopause. These signs and symptoms include night sweats, vaginal dryness, hot flashes, abnormal menstrual cycles, difficulty sleeping, mood swings, and others.

Middle East and Africa Menopausal Disorder Treatment Market Dynamics

Drivers

• Increasing Demand of Herbal Treatments

With each passing decade, women are inclining more towards herbal supplements as a part of their menopause treatment which is one of the market's most significant latest developments. As a result, numerous companies are responding to the market need by manufacturing latest products which contain menopause-relieving components. For instance, black cohosh and soy isoflavones are the two natural remedies that worked well for menopause. The prevalence of menopausal disorder among menopaused women was expected around 54.87% in the Middle East countries. Thus, this disorder demands a huge increase of treatment, increasing the market growth rapidly.

• Increased Incidence Rate of Menopause

The World Health Organization estimates a rise in the proportion of adults over age 60 years in sub-Saharan Africa from 46 million people in 2015 to 157 million by 2050. Likewise, sub-Saharan African women can expect an increased life expectancy at 76 years. The occurrence of women experiencing menopause, commonly between the ages of 45 and 55 years, will also markedly increase. Furthermore, the 2007 National Census estimated 9.7 million women aged 30 years or older with 2.1 million in the menopausal age range of 45 to 55 years in Ethiopia alone. Thus, this boosts the market growth.

 Opportunities

• Major Impact of Trending Lifestyle and Stress

In recent years, it has become positively important to provide women with much effective therapy for menopause symptoms because of the rise in the occurrence of physical and mental health issues among women. Factors such as migraine, anxiety, irritability, formication, fatigue, hot flashes, mood swings, and insomnia, contribute a lot to many companies to develop cutting-edge therapies to improve these symptoms. Huge growth in the menopause therapy industry is being aided by widespread investments in extended R&D initiatives to launch novel medications. This factor is helping the market growth in a great way.

• Increasing Demand of Hormone Therapy

Hormone therapy is anticipated to present high growth during the forecast period. The most effective and widely accepted method of treating menopausal heat flashes is estrogen medication, increasing market growth. Hormone therapy is extensively accepted for a long time due to its efficiency and improvement in women’s health. Therefore, this factor accelerates the growth of the market.

Restraints/Challenges

• Growing Underlying Disparities Between Genders

Numerous companies providing multiple treatments for menopause have struggled considerably due to the extensive existence of major gender-wise health disparities in many of the nations. Women in nations with limited awareness and income see no gains in their health due to the lack of adequate healthcare infrastructure. This acts as a major restriction for the market.  

• Side Effects of Hormone Therapy

As per the guidelines of FDA, there are several complications related with hormone therapy that carry various hazards, that includes the possibility of heart problems, stroke, blood clots, and breast cancer. Thus, it hampers the market growth.   

This menopausal disorder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the menopausal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Middle East and Africa Menopausal disorder Treatment Market

The menopausal disorder treatment market is segmented on the basis of stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Stages

• Menopause
• Postmenopause
• Perimenopause

Type

• Hormonal Therapy
• Non-Hormonal Therapy

Menopause Symptoms

• Vasomotor Symptoms
• Atrophic Vaginitis
• Osteoporosis
• Joint Pain
• Weight Gain
• Dyspareunia
• Depression
• Others

Dosage Form

• Tablet
• Cream

• Gels
• Rings/Insert
• Patch/Film
• Injection Shot
• Spray
• Others

Route of Administration

• Oral
• Vaginal
• Transdermal
• Parenteral

End User

• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Other

Middle East and Africa Menopausal Disorder Treatment Market Regional Analysis/Insights

The menopausal disorder treatment market is analyzed and market size insights and trends are provided by stages, type, menopause symptoms, dosage form, route of administration, end-user and distribution channel as referenced above.

The major countries covered in the menopausal disorder treatment market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Saudi Arabia is leading the menopausal disorder treatment market due to the increase in prevalence of hormonal & reproductive disorders in among female. Furthermore, the country witnessed advanced medical environment, a life expectancy for people over 80 years that is actually more compared to other regions, and minimized heart attack and stroke death rates than those in similar countries. Thus, all these factors led to the market growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Middle East and Africa Menopausal Disorder Treatment Market Share Analysis

The menopausal disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to menopausal disorder treatment market

Key players operating in the menopausal disorder treatment market t include:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Johnson & Johnson Private Limited (U.S.)
• Merck & Co., Inc. (U.S.)
• Eli Lilly and Company (U.S.)
• Abbott (U.S.)
• Novo Nordisk A/S (Denmark)
• Abbvie, Inc (U.S.)
• Dr. Reddy’s Laboratories Ltd. (India)
• TherapeuticsMD, Inc. (U.S.)
• Ipsen Pharma (France)
• Besins Healthcare (Belgium)
• Mithra Pharmaceuticals (Belgium)
• Aché Laboratórios Farmacêuticos S.A (Brazil)
• SEBELA PHARMACEUTICALS (U.S.)
• Fervent Pharmaceuticals Inc. (U.S.)
• KaNDy Therapeutics (U.K.)
• Duchesnay USA (U.S.)